GlassScriptPhysician profile
J Riley Stringham
NPI 1588872691
$13,065.32
in general payments reported to CMS, 2019-2025
40 companies · $657 in 2025
The $657 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,304 · 2020: $287 · 2021: $537 · 2022: $633 · 2023: $574 · 2024: $8,073 · 2025: $657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $7,589 · Food and Beverage: $1,715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $7,589.20 |
| Food and Beverage | $1,714.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| International Rehabilitative Sciences, INC | $7,602.22 | 2023-2024 | Rs-Lbg, Rs-Fbg, Rs4i Plus Sequential Stimulator, Rs 4i Plus Sequential Stimulator |
| Vertiflex, INC. | $1,710.45 | 2019 | |
| Boston Scientific Corporation | $479.29 | 2019-2025 | Wavewriter Alpha Prime 16, General - Therapies |
| Abbott Laboratories | $432.36 | 2019-2025 | Eterna |
| Nevro Corp. | $376.60 | 2019-2024 | Senza |
| Medtronic, INC. | $268.52 | 2021-2025 | Inceptiv, Intellis Adaptivestim, Closurefast |
| Biotronik Nro, INC. | $258.95 | 2025 | Prospera |
| Abbvie INC. | $220.93 | 2021-2025 | Qulipta, Ubrelvy |
| Saluda Medical Americas, INC. | $171.96 | 2024-2025 | Evoke |
| Averitas Pharma INC. | $166.69 | 2023-2025 | Qutenza |
| Relievant Medsystems, INC. | $151.81 | 2021-2022 | |
| Tersera Therapeutics LLC | $144.84 | 2019-2025 | Prialt |
| Spr Therapeutics, INC | $118.64 | 2021-2025 | Sprint Pns System |
| Acacia Pharma INC | $114.73 | 2021-2022 | |
| Medtronic USA, INC. | $112.94 | 2019-2020 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw J Riley Stringham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.